We will do our best for your study being successful
Home
Solutions
Expertise
Сontacts
Trust on conducting studies to NEA Clinical
Why Megalek
CLINICAL TRIALS IN FRANCE
France is one of the most active players today, with one in ten clinical trials in the world being conducted in France.France has one of the oldest and most robust vintage research structures in the world. France has a large base of research centres and hospitals with extensive experience in conducting clinical trials, with pre-trained and trained staff with extensive experience and knowledge in various therapeutic areas.

France is home to over 66 million people who provide a large sample for clinical trials. In France, there is full compliance with all European standards and principles, which guarantees the accuracy and reliability of the clinical trial at all stages of the study. Full accountability of the entire clinical trial is also guaranteed.

The regulatory framework is in line with the system and principles of European pharmacology. All trial applications are submitted to the French National Agency for the Safety of Medicines and Medical Devices (ANSM) and the Ethics Committee, where they are reviewed within 60 days.
CLINICAL DEVELOPMENT SOLUTIONS OVERVIEW
CLINICAL TRIALS IN FRANCE
France is one of the most active players today, with one in ten clinical trials in the world being conducted in France.France has one of the oldest and most robust vintage research structures in the world. France has a large base of research centres and hospitals with extensive experience in conducting clinical trials, with pre-trained and trained staff with extensive experience and knowledge in various therapeutic areas.

France is home to over 66 million people who provide a large sample for clinical trials. In France, there is full compliance with all European standards and principles, which guarantees the accuracy and reliability of the clinical trial at all stages of the study. Full accountability of the entire clinical trial is also guaranteed.

The regulatory framework is in line with the system and principles of European pharmacology. All trial applications are submitted to the French National Agency for the Safety of Medicines and Medical Devices (ANSM) and the Ethics Committee, where they are reviewed within 60 days.
Therapeutic areas IN FRANCE:
  • Oncology
  • Hematology
  • Metabolic
  • Central nervous system (CNS)
  • Dermatology
  • Cardiovascular
  • Dermatology
  • Endocrinology
  • Hematology
  • Immunology
  • Rheumatology
  • Infections and Infectious Diseases